↓ Skip to main content

A double-blind randomized placebo controlled study assessing safety, tolerability and efficacy of palmitoylethanolamide for symptoms of knee osteoarthritis

Overview of attention for article published in Inflammopharmacology, March 2019
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#49 of 682)
  • High Attention Score compared to outputs of the same age (88th percentile)
  • High Attention Score compared to outputs of the same age and source (83rd percentile)

Mentioned by

news
2 news outlets
twitter
1 X user
patent
1 patent
video
1 YouTube creator

Citations

dimensions_citation
29 Dimensions

Readers on

mendeley
110 Mendeley
Title
A double-blind randomized placebo controlled study assessing safety, tolerability and efficacy of palmitoylethanolamide for symptoms of knee osteoarthritis
Published in
Inflammopharmacology, March 2019
DOI 10.1007/s10787-019-00582-9
Pubmed ID
Authors

Elizabeth Steels, Ruchitha Venkatesh, Eleanor Steels, Gemma Vitetta, Luis Vitetta

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 110 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 110 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 20 18%
Researcher 14 13%
Student > Master 14 13%
Other 8 7%
Student > Doctoral Student 6 5%
Other 16 15%
Unknown 32 29%
Readers by discipline Count As %
Medicine and Dentistry 28 25%
Nursing and Health Professions 15 14%
Neuroscience 6 5%
Psychology 6 5%
Agricultural and Biological Sciences 4 4%
Other 19 17%
Unknown 32 29%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 21. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 April 2023.
All research outputs
#1,810,318
of 25,552,933 outputs
Outputs from Inflammopharmacology
#49
of 682 outputs
Outputs of similar age
#40,506
of 364,558 outputs
Outputs of similar age from Inflammopharmacology
#3
of 12 outputs
Altmetric has tracked 25,552,933 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 682 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.4. This one has done particularly well, scoring higher than 92% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 364,558 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 12 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 83% of its contemporaries.